Rubicon Organics Valuation Multiples

Discover revenue and EBITDA valuation multiples for Rubicon Organics and similar public comparables like iAnthus Capital Holdings, MariMed, Mountain Valley MD Hldgs, ZYUS Life Sciences and more.

Rubicon Organics Overview

About Rubicon Organics

Rubicon Organics Inc is engaged in the business of the production and sale of cannabis in Canada. The Company produces and processes organic cannabis at its wholly-owned, federally licensed facility in Delta, British Columbia which it sells under its wholly owned and other licensed brands such as Lab Theory, Wildflower, Homestead Cannabis Supply, 1964 Supply Co, and Simply Bare Organic.


Founded

2015

HQ

Canada

Employees

210

Financials (LTM)

Revenue: $49M
EBITDA: $4M

EV

$30M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Rubicon Organics Financials

Rubicon Organics reported last 12-month revenue of $49M and EBITDA of $4M.

In the same LTM period, Rubicon Organics generated $15M in gross profit, $4M in EBITDA, and $482K in net income.


Rubicon Organics P&L

In the most recent fiscal year, Rubicon Organics reported revenue of $43M and EBITDA of $4M.

Rubicon Organics is profitable as of last fiscal year, with gross margin of 37%, EBITDA margin of 9%, and net margin of 2%.

See analyst estimates for Rubicon Organics
LTMLast FY202320242025202620272028
Revenue$49M$43M$29M$35M$43M
Gross Profit$15M$16M$9M$11M$16M
Gross Margin31%37%33%32%37%
EBITDA$4M$4M$2M$1M$4M
EBITDA Margin8%9%6%4%9%
EBIT Margin2%3%(3%)(2%)3%
Net Profit$482K$754K($1M)($2M)$754K
Net Margin1%2%(5%)(5%)2%
Net Debt-$6M---

Financial data powered by Morningstar, Inc.

Rubicon Organics Stock Performance

Rubicon Organics has current market cap of $22M, and enterprise value of $30M.


Rubicon Organics' stock price is $0.33.

Rubicon Organics has an EPS (earnings per share) of $0.01.

See more trading valuation data for Rubicon Organics
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$30M$22M-8.1%---$0.01

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Rubicon Organics Valuation Multiples

Rubicon Organics trades at 0.6x EV/Revenue multiple, and 7.5x EV/EBITDA.

See NTM and 2027E valuation multiples for Rubicon Organics

Rubicon Organics Financial Valuation Multiples

As of August 14, 2026, Rubicon Organics has market cap of $22M and EV of $30M.

Rubicon Organics has a P/E ratio of 46.3x.

LTMLast FY202320242025202620272028
EV/Revenue0.6x0.7x1.0x0.8x0.7x
EV/EBITDA7.5x8.1x17.2x22.2x8.1x
EV/EBIT31.5x22.6x(38.1x)(35.3x)22.6x
EV/Gross Profit1.9x1.9x3.1x2.7x1.9x
P/E46.3x29.6x(17.0x)(12.1x)29.6x
EV/FCF(6.8x)(3.6x)17.8x22.3x(3.6x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Rubicon Organics Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Rubicon Organics Margins & Growth Rates

Rubicon Organics grew revenue by 23% and EBITDA by 13% in the last fiscal year.

In the most recent fiscal year, Rubicon Organics reported gross margin of 37%, EBITDA margin of 9%, and net margin of 2%.

See estimated margins and future growth rates for Rubicon Organics

Rubicon Organics Margins

Last FY202420252026202720282029
Gross Margin37%32%37%31%
EBITDA Margin9%4%9%8%
EBIT Margin3%(2%)3%1%
Net Margin2%(5%)2%1%
FCF Margin(19%)4%(19%)(4%)

Rubicon Organics Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth23%21%22%23%
Gross Profit Growth1%17%44%1%
EBITDA Growth13%(23%)175%13%
EBIT Growth(45%)8%(256%)(45%)
Net Profit Growth(62%)41%(141%)(62%)
FCF Growth(76%)(20%)(718%)(76%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Rubicon Organics Operational KPIs

Rubicon Organics' revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Rubicon Organics' Rule of 40 is 31% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Rubicon Organics' Rule of X is 65% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Rubicon Organics
LTMLast FY202320242025202620272028
Rule of 4027%31%---
Bessemer Rule of X56%65%---
Revenue per Employee-$0.2M---
Opex per Employee-$0.1M---
S&M Expenses to Revenue-7%5%5%7%
G&A Expenses to Revenue-27%29%29%27%
Opex to Revenue-34%35%34%34%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Rubicon Organics Competitors

Rubicon Organics competitors include iAnthus Capital Holdings, MariMed, Mountain Valley MD Hldgs, ZYUS Life Sciences, Peak Processing, Avicanna, Vitura Health, HYTN Innovations, Humanoid Global Holdings and PharmaCielo.

Most Rubicon Organics public comparables operate across Cannabis, CannaTech and ViceTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
iAnthus Capital Holdings1.7x-14.0x-
MariMed0.7x0.7x13.4x6.7x
Mountain Valley MD Hldgs380.5x-(10.9x)-
ZYUS Life Sciences152.3x-(3.7x)-
Peak Processing1.6x-(8.1x)-
Avicanna0.6x-(8.2x)-
Vitura Health0.2x-3.2x-
HYTN Innovations8.9x-(13.0x)-

This data is available for Pro users. Sign up to see all Rubicon Organics competitors and their valuation data.

Start Free Trial

Rubicon Organics VC Funding History

Before going public, Rubicon Organics raised $9M in total equity funding, across 1 round.


Rubicon Organics Funding Rounds

DateStageInvestorsRaisedValuationRev. MultipleDeal Summary
Jul-18Series A-$9M--

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Rubicon Organics

When was Rubicon Organics founded?Rubicon Organics was founded in 2015.
Where is Rubicon Organics headquartered?Rubicon Organics is headquartered in Canada.
How many employees does Rubicon Organics have?As of today, Rubicon Organics has over 210 employees.
Is Rubicon Organics publicly listed?Yes, Rubicon Organics is a public company listed on Toronto Stock Exchange.
What is the stock symbol of Rubicon Organics?Rubicon Organics trades under ROMJ ticker.
When did Rubicon Organics go public?Rubicon Organics went public in 2018.
Who are competitors of Rubicon Organics?Rubicon Organics main competitors include iAnthus Capital Holdings, MariMed, Mountain Valley MD Hldgs, ZYUS Life Sciences, Peak Processing, Avicanna, Vitura Health, HYTN Innovations, Humanoid Global Holdings, PharmaCielo.
What is the current market cap of Rubicon Organics?Rubicon Organics' current market cap is $22M.
What is the current revenue of Rubicon Organics?Rubicon Organics' last 12 months revenue is $49M.
What is the current revenue growth of Rubicon Organics?Rubicon Organics revenue growth (NTM/LTM) is 19%.
What is the current EV/Revenue multiple of Rubicon Organics?Current revenue multiple of Rubicon Organics is 0.6x.
What is the current EBITDA of Rubicon Organics?Rubicon Organics' last 12 months EBITDA is $4M.
What is Rubicon Organics' EBITDA margin?Rubicon Organics' last 12 months EBITDA margin is 8%.
What is the current EV/EBITDA multiple of Rubicon Organics?Current EBITDA multiple of Rubicon Organics is 7.5x.
What is the current FCF of Rubicon Organics?Rubicon Organics' last 12 months FCF is ($4M).
What is Rubicon Organics' FCF margin?Rubicon Organics' last 12 months FCF margin is (9%).
What is the current EV/FCF multiple of Rubicon Organics?Current FCF multiple of Rubicon Organics is (6.8x).
How many companies Rubicon Organics has acquired to date?Rubicon Organics hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Rubicon Organics has invested to date?Rubicon Organics hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Rubicon Organics

Lists including Rubicon Organics

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial